Schedule 13G ownership disclosure

First Tracks Biotherapeutics, Inc.

Common Stock, $0.001 par value per share · CUSIP: 337185102

Event date: 2026-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Adage Capital Management, L.P.

    Shares: 2,077,179.00 · Class: 5.81%

  • Robert Atchinson

    Shares: 2,077,179.00 · Class: 5.81%

  • Phillip Gross

    Shares: 2,077,179.00 · Class: 5.81%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-26-007578
Form type
SCHEDULE 13G
Filer
First Tracks Biotherapeutics, Inc.
CIK
CIK 2091349
Filed
Nov 12, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub